Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response.
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2016
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics; Pharmacogenomic
- 28 Oct 2016 Status changed from recruiting to completed.
- 01 Oct 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Oct 2014 to 1 Dec 2014.
- 17 Oct 2013 Planned end date changed from 26 Jan 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.